This topic contains a solution. Click here to go to the answer

Author Question: Which are qualifying terms located after ICD-10-CM index main terms, which do not have to be ... (Read 233 times)

Yi-Chen

  • Hero Member
  • *****
  • Posts: 550
Which are qualifying terms located after ICD-10-CM index main terms, which do not have to be included in the diagnostic or procedural statement for the code number listed after the parentheses to be assigned?
 a. essential modifiers
 b. inclusion terms
 c. nonessential modifiers
  d. subterms

Question 2

ICD-10-CM index main terms are printed in __________ type, and subterms and qualifiers are indented below main terms.
 a. boldfaced
 b. italicized
 c. quoted
 d. underlined



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ApricotDream

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

c

Answer to Question 2

a





 

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library